Dakshina Reddy

Dakshina Reddy worked as an Executive Director of Drug Regulatory Affairs at Galectin Therapeutics, Inc. and as a Director of Global Program Regulatory at Novartis AG.
From 2022 to 2024, Mr. Reddy served as the Vice President of Regulatory Affairs at Altimmune, Inc. Mr. Reddy completed a graduate degree at the University of the Witwatersrand and an undergraduate degree at Rhodes University.